Gerlach M - Search Results

1

Caenorhabditis elegans MPP+ model of Parkinson's disease for high-throughput drug screenings.

Braungart E, Gerlach M, Riederer P, Baumeister R, Hoener MC. Braungart E, et al. Among authors: gerlach m. Neurodegener Dis. 2004;1(4-5):175-83. doi: 10.1159/000080983. Neurodegener Dis. 2004. PMID: 16908987

2

The molecular pharmacology of L-deprenyl.

Gerlach M, Riederer P, Youdim MB. Gerlach M, et al. Eur J Pharmacol. 1992 Jun 5;226(2):97-108. doi: 10.1016/0922-4106(92)90170-z. Eur J Pharmacol. 1992. PMID: 1639115 Review.

3

Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?

Russ H, Mihatsch W, Gerlach M, Riederer P, Przuntek H. Russ H, et al. Among authors: gerlach m. Neurosci Lett. 1991 Feb 11;123(1):115-8. doi: 10.1016/0304-3940(91)90171-o. Neurosci Lett. 1991. PMID: 1712088

4

MPTP mechanisms of neurotoxicity and their implications for Parkinson's disease.

Gerlach M, Riederer P, Przuntek H, Youdim MB. Gerlach M, et al. Eur J Pharmacol. 1991 Dec 12;208(4):273-86. doi: 10.1016/0922-4106(91)90073-q. Eur J Pharmacol. 1991. PMID: 1815982 Review.

5

Treatment with antioxidants does not prevent loss of dopamine in the striatum of MPTP-treated common marmosets: preliminary observations.

Mihatsch W, Russ H, Gerlach M, Riederer P, Przuntek H. Mihatsch W, et al. Among authors: gerlach m. J Neural Transm Park Dis Dement Sect. 1991;3(1):73-8. doi: 10.1007/BF02251138. J Neural Transm Park Dis Dement Sect. 1991. PMID: 1905937

6

Altered brain metabolism of iron as a cause of neurodegenerative diseases?

Gerlach M, Ben-Shachar D, Riederer P, Youdim MB. Gerlach M, et al. J Neurochem. 1994 Sep;63(3):793-807. doi: 10.1046/j.1471-4159.1994.63030793.x. J Neurochem. 1994. PMID: 7519659 Review.

7

Regional distribution and characterization of nitric oxide synthase activity in the brain of the common marmoset.

Gerlach M, Oehler D, Blum-Degen D, Lange KW, Mayer B, Reichmann H, Riederer P. Gerlach M, et al. Neuroreport. 1995 May 30;6(8):1141-5. doi: 10.1097/00001756-199505300-00017. Neuroreport. 1995. PMID: 7545017

8

Neuroprotective therapeutic strategies. Comparison of experimental and clinical results.

Gerlach M, Riederer P, Youdim MB. Gerlach M, et al. Biochem Pharmacol. 1995 Jun 29;50(1):1-16. doi: 10.1016/0006-2952(95)00051-z. Biochem Pharmacol. 1995. PMID: 7605334 Review. No abstract available.

9

Pretreatment with nimodipine prevents MPTP-induced neurotoxicity at the nigral, but not at the striatal level in mice.

Kupsch A, Gerlach M, Pupeter SC, Sautter J, Dirr A, Arnold G, Opitz W, Przuntek H, Riederer P, Oertel WH. Kupsch A, et al. Among authors: gerlach m. Neuroreport. 1995 Mar 7;6(4):621-5. doi: 10.1097/00001756-199503000-00009. Neuroreport. 1995. PMID: 7605913

10

Mössbauer spectroscopic studies of purified human neuromelanin isolated from the substantia nigra.

Gerlach M, Trautwein AX, Zecca L, Youdim MB, Riederer P. Gerlach M, et al. J Neurochem. 1995 Aug;65(2):923-6. doi: 10.1046/j.1471-4159.1995.65020923.x. J Neurochem. 1995. PMID: 7616255

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

486 results

Search Page

Filters